Feedback / Questions
Rubraca (rucaparib) - Clovis
firtecan pegol (PEG-SN38) - Zhejiang Hisun, Belrose
PLX038 - ProLynx
http://www.globenewswire.com/news-release/2020/04/13/2015179/0/fr/ProLynx-annonce-l-essai-clinique-de-phase-1B-de-son-agent-endommageant-l-ADN-PLX038-PEG-SN-38-associ%C3%A9-%C3%A0-l-inhibiteur-de-la-PARP-Rubraca-rucaparib-au-National-Cancer-Institute.html
Apr 13, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next